Time-Restricted Fasting Improves Liver Steatosis in Non-Alcoholic Fatty Liver Disease—A Single Blinded Crossover Trial
Nutrients · 22.11.2023 · 15 (23) · 4870
DOI: 10.3390/nu15234870 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, online erschienen am 22.11.2023. Verfasst von Jack Feehan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Health and Sport, Victoria University, Melbourne 3011, Australia. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Non-alcoholic fatty liver disease (NAFLD) is associated with visceral adiposity. We assessed the effectiveness of time-restricted fasting (TRF) for 16 h daily without calorie restrictions compared to standard care (SC; diet and lifestyle advice) in improving visceral adiposity and steatosis via controlled attenuation parameter (CAP).
Methods
In a prospective single-blind randomized controlled trial, 32 participants with NAFLD were randomly assigned to TRF or SC for 12 weeks. The secondary endpoints were changes in liver stiffness, anthropometry, blood pressure, and other metabolic factors.
Results
Twenty-eight participants completed the first arm of the study (TRF = 14, SC = 14), with 23 completing the crossover arm (TRF = 10, SC = 13). The baseline demographics were similar between the groups. Intermittent fasting caused a significant decrease in hepatic steatosis (p = 0.038), weight (p = 0.005), waist circumference (p = 0.001), and BMI (p = 0.005) compared to standard care. Intermittent fasting also resulted in additional within-group changes that were not seen in the standard care intervention.
Conclusion
TRF offers superior improvements in patients with NAFLD, improving steatosis, weight, and waist circumference despite a lack of change in overall caloric intake. Time-restricted fasting should be considered as a primary weight loss intervention in the context of NAFLD.
Trial registration
ACTRN12613000935730.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Health and Sport, Victoria University, Melbourne 3011, Australia.
- School of Clinical Sciences, Monash University, Melbourne 3168, Australia.
- Department of Nursing and Allied Health, Swinburne University of Technology, Hawthorn 3122, Australia.
- Gastroenterology and Hepatology Unit, Monash Health, Melbourne 3168, Australia.
- School of Health and Biomedical Sciences, RMIT, Bundoora 3083, Australia.
ORCID-Profile: Jack Feehan, Darcy Q Holt, William Sievert, Gregory T Moore, Barbora de Courten, Alexander Hodge
Zitieren
APA
Feehan, J., Mack, A., Tuck, C., Tchongue, J., Holt, D. Q., Sievert, W., Moore, G. T., de Courten, B., & Hodge, A. (2023). Time-Restricted Fasting Improves Liver Steatosis in Non-Alcoholic Fatty Liver Disease—A Single Blinded Crossover Trial. Nutrients, 15(23), 4870. https://doi.org/10.3390/nu15234870
Vancouver
Feehan J, Mack A, Tuck C, Tchongue J, Holt DQ, Sievert W, et al. Time-Restricted Fasting Improves Liver Steatosis in Non-Alcoholic Fatty Liver Disease—A Single Blinded Crossover Trial. Nutrients. 2023;15(23):4870. doi:10.3390/nu15234870
BibTeX
@article{Feehan2023,
author = {Feehan, Jack and Mack, Alexandra and Tuck, Caroline and Tchongue, Jorge and Holt, Darcy Q and Sievert, William and Moore, Gregory T and de Courten, Barbora and Hodge, Alexander},
title = {Time-Restricted Fasting Improves Liver Steatosis in Non-Alcoholic Fatty Liver Disease—A Single Blinded Crossover Trial},
journal = {Nutrients},
year = {2023},
volume = {15},
number = {23},
pages = {4870},
doi = {10.3390/nu15234870}
}
EUVIMED